The dose of antibiotics consumed in Brazil is the highest in the world as reported by the World Health Organization (WHO) published on Monday (June 12th). This is the consequence of selecting this type of medicine. The main concern of the Agency is that excessive consumption contributes to the emergence of a large number of bacteria that can cause serious infections that can be challenging.
The WHO survey contains data from 65 countries where statistical data are collected. The indicator used was the number of daily doses consumed by thousands of people. In Brazil, the index was 22 SD per thousand people, which is the 17th largest consumer of 65 countries surveyed.
In Europe, an average of 18 doses, measured in Canada and Japan, was 17 and 14 DD, respectively. The report shows a major change in drug consumption among countries. Indonesia has moved to Burundi (Africa) from 64 to 4 in Mongolia (Asia).
WHO and experts note, however, that very low levels of consumption are also unacceptable. In the opinion of the Agency, the big difference in the use of antibiotics in the world is that some countries abuse the consumption, while others may not have enough of these drugs.
Medical Director, Director of Microbiology Service of the Central Clinical Laboratory, das Clínicas, Flavia Rossi agrees with the analysis of the organization. In Brazil, he said, measures would be taken to reduce consumption, saying that "patience and care are worrying too."
"One of the main activities is investing in diagnostic techniques, namely for medication precision, mainly in the microbiology laboratories in the state system, and the physician and the patient know the disease, the microorganisms that cause the disease," says WHO, Flavia, a member of the expert group invited to discuss the Protocol on rational use of antibiotics.
Suzanne Hill, head of the WHO Core Unit, says that this is a misuse that has led to increased bacterial resistance to products. It says patients will be able to resist antibiotics and to "immune" the drug when it is unnecessary or when used to cure the treatment.
In contrast, the Pan-American Infectious Disease Association, in partnership with pharmaceutical company Pfizer, launched a campaign to increase awareness of patients about rational use of drugs this week. "The idea of appointing a physician and correctly disposing of drugs is the idea that small acts can save millions of lives," said Eurico Correia Medical Director Pfizer.
Only 250,000 people die each year against tuberculosis antibiotics. Additionally, WHO has identified 12 more cases that threaten endurance products in the market.
In total, 51 new antibiotics are at different stages of assessment and testing. Of these, only eight out of WHO are classified as 'innovative treatments'. Even though they are not a complete guarantee of hope in this area, they need to go through all the clinical trials to reach the market.
Proper use of antibiotics should be solved not only between people, but also in the agricultural sector. Today, 70% of all drug-consuming drugs worldwide are used in the food and animal sector, which has initiated discussions with the World Health Organization (WHO) on measures to reduce animal exploitation.
"In the agricultural sector, antibiotics are intended to treat animal diseases and increase their weight, which should be kept at least," said Flava Rossi, Medical Director of the Central Laboratory of Microbiology. Clinic.
Brazil is part of an international group of experts called WHO, discussing ways to reduce the use of these drugs. Last year, the group made the classification of antibiotics used in each group (human or animal).
"From this classification and research, we make protocols and proposals, and I am confident Brazil and other countries will follow this downward trend, because it's a global demand," says Flavia. "In the United States, for example, it shows that there are antibiotics in major meat companies," she said.
It indicates that WHO's goal is to achieve an adequate level of antibiotics in humans and animals by 2050. If the agency does nothing, the number of deaths from bacterial malformations is at least 10 million per year, for example, the number of cancer patients (8.2 million). Today, more than 700,000 people die annually for infections that are resistant to bacteria in the world.
According to Flavia, the most commonly encountered bacteria in persistent infections are the well-known Klebsiella Pneumoniae Carbapenemase (KPC) in several Brazilian hospitals. The most vulnerable to endemic infections are children, the elderly and the sick, who have conditions that deteriorate the immune system such as autoimmune diseases, malignant neoplasms or HIV. Information in the newspaper S. PAULU STATE.